Literature DB >> 233695

A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin D.

S J Marx, A M Spiegel, E M Brown, D G Gardner, R W Downs, M Attie, A J Hamstra, H F DeLuca.   

Abstract

Typical features of hereditary vitamin D-dependent (pseudovitamin D-deficient) rickets were observed beginning at ages 20 and 5 months in a brother and sister. Both had calcium malabsorption correctable with high doses of 25-hydroxyvitamin D. During periods of hypocalcemia they both manifested secondary hyperparathyroidism with hypophosphatemia and high serum concentrations of endogenously produced 1,25-dihydroxyvitamin D. In each, normalization of serum calcium concentration and resolution of osteomalacia were obtained with continuous administration of high doses of ergocalciferol or high doses of 1,25-dihydroxycholecalciferol. Chemical features of vitamin D deficiency were corrected in the presence of high circulating concentrations of 1,25-dihydroxyvitamin D2, produced endogenously, or of 1,25-dihydroxyvitamin D3, administered by mouth. Serum concentrations of 25-hydroxyvitamin D2, 25-hydroxyvitamin D3, 24,25-dihydroxyvitamin D, and 1,25-dihydroxyvitamin D were normal in five first degree relatives. We conclude that in these five first degree relatives. We conclude that in these siblings, rickets and osteomalacia resulted from a hereditary decreased sensitivity to 1,25-dihydroxyvitamin D at the intestine and perhaps other vitamin D target tissues.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 233695     DOI: 10.1210/jcem-47-6-1303

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

Review 1.  Molecular genetics of mineral metabolic disorders.

Authors:  R V Thakker
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

Review 2.  Vitamin D-endocrine system.

Authors:  N H Bell
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

3.  A humanized mouse model of hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia.

Authors:  Seong Min Lee; Joseph J Goellner; Charles A O'Brien; J Wesley Pike
Journal:  Endocrinology       Date:  2014-08-22       Impact factor: 4.736

4.  Failure to heal D-deficiency rickets and suppress secondary hyperparathyroidism with conventional doses of 1,25-dihydroxy vitamin D3.

Authors:  T Cundy; J A Kanis; G Heynen; M Earnshaw; T L Clemens; J L O'Riordan; A L Merrett; J E Compston
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-20

5.  Vitamin D-dependent rickets type II.

Authors:  N H Bell
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

6.  CYP2R1 Mutations Impair Generation of 25-hydroxyvitamin D and Cause an Atypical Form of Vitamin D Deficiency.

Authors:  Tom D Thacher; Philip R Fischer; Ravinder J Singh; Jeffrey Roizen; Michael A Levine
Journal:  J Clin Endocrinol Metab       Date:  2015-05-05       Impact factor: 5.958

7.  Vitamin D-dependent rickets type II: extreme end organ resistance to 1,25-dihydroxy vitamin D3 in a patient without alopecia.

Authors:  L J Fraher; R Karmali; F R Hinde; G N Hendy; H Jani; L Nicholson; D Grant; J L O'Riordan
Journal:  Eur J Pediatr       Date:  1986-10       Impact factor: 3.183

8.  The mechanism of end-organ resistance to 1 alpha,25-dihydroxycholecalciferol in the common marmoset.

Authors:  N Takahashi; S Suda; T Shinki; N Horiuchi; Y Shiina; Y Tanioka; H Koizumi; T Suda
Journal:  Biochem J       Date:  1985-04-15       Impact factor: 3.857

9.  Resistance to 1,25-dihydroxyvitamin D. Association with heterogeneous defects in cultured skin fibroblasts.

Authors:  U A Liberman; C Eil; S J Marx
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

10.  Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.

Authors:  M K Drezner; K W Lyles; M R Haussler; J M Harrelson
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.